Neurology · 4 h ago
ADOPIC cognitive composites predict amyloid-related decline and progression to mild cognitive impairment
An observational analysis of 1,964 cognitively unimpaired participants developed and validated cognitive composites using harmonized ADOPIC cohort data. In the longitudinal subset of 1,110 participants, general cognition showed sensitivity comparable to the ADCS-PACC, and all composites significantly predicted progression to mild cognitive impairment.
- Study included 1,964 cognitively unimpaired participants; 1,110 had longitudinal data.
- General cognition performed comparably to the ADCS-PACC.
- All composites significantly predicted progression to mild cognitive impairment.
- Abstract-only reporting limits assessment of predictive precision and clinical applicability.
Researchers in the Alzheimer's Dementia Onset and Progression in International Cohorts (ADOPIC) study developed and validated data-driven cognitive composites to track amyloid beta (Aβ)-related cognitive decline. The observational analysis included 1,964 cognitively unimpaired participants at baseline, with 1,110 in the longitudinal subset. Principal component analysis-derived domain-specific and general cognition composites were assessed for psychometric properties, sensitivity to Aβ-related decline, and prediction of progression to mild cognitive impairment (MCI), using the ADCS-PACC as a comparator.
The composites showed good to excellent psychometric properties and differentiated cognitive trajectories associated with Aβ status (p < 0.001). The general cognition composite demonstrated longitudinal sensitivity comparable to the ADCS-PACC, with a reported effect size of d = −0.20, and equivalent classification performance, with an area under the receiver operating characteristic curve of 0.70. All composites significantly predicted MCI progression (p < 0.001).
These findings support the composites as potential outcome measures in preclinical Alzheimer's disease research, including domain-specific assessment. They do not establish superiority over the ADCS-PACC. Only the abstract was available; follow-up duration, MCI event counts, confidence intervals, and details of cohort validation were not provided, limiting assessment of predictive precision and applicability to individual clinical decisions.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Alzheimer's & Dementia: Data‑driven cognitive composites predict Aβ‑related decline and progression to MCI: the ADOPIC study ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.
